Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Muscular Atrophy [NCBI]


Gene


Gene Link Information
Gain
01
LGMD2L [NCBI] 0.000367544
CMT2G [NCBI] 0.000367544
SCA18 [NCBI] 0.000306807
IBM3 [NCBI] 0.000306807
MSTN [NCBI] 0.000289946
FBXO32 [NCBI] 0.000285559
TRIM63 [NCBI] 0.000270465
TRNS1 [NCBI] 0.0002208
FOP [NCBI] 0.000139779
MUSK [NCBI] 6.20467e-05
MYOD1 [NCBI] 5.2334e-05
FOXO1 [NCBI] 4.48975e-05
SOD1 [NCBI] 4.43185e-05
HSPB8 [NCBI] 3.45523e-05
BSCL2 [NCBI] 2.3834e-05
NOS1 [NCBI] 2.04726e-05
CAPN3 [NCBI] 1.97268e-05
FOXO3 [NCBI] 1.88652e-05
MPZ [NCBI] 1.86821e-05
DYSF [NCBI] 1.71446e-05
SETX [NCBI] 1.6826e-05
TCAP [NCBI] 1.63684e-05
CASP3 [NCBI] 1.53256e-05
AMPD1 [NCBI] 1.47959e-05
NEFH [NCBI] 1.43154e-05
FBXO40 [NCBI] 1.41588e-05
MFN2 [NCBI] 1.40698e-05
HTT [NCBI] 1.405e-05
IGF1 [NCBI] 1.16651e-05
CTSL1 [NCBI] 1.11812e-05
TTR [NCBI] 1.09427e-05
CS [NCBI] 1.08831e-05
MB [NCBI] 1.05868e-05
ALG2 [NCBI] 9.51895e-06
ARNTL2 [NCBI] 9.51895e-06
DMD [NCBI] 9.51742e-06
NEFL [NCBI] 9.44373e-06
SKP1 [NCBI] 9.23186e-06
CUL1 [NCBI] 8.7714e-06
ANKRD2 [NCBI] 8.7714e-06
RBX1 [NCBI] 8.40911e-06
RB1CC1 [NCBI] 8.40911e-06
FHL1 [NCBI] 8.25323e-06
MYF5 [NCBI] 7.97865e-06
UBR1 [NCBI] 7.97865e-06
SPG20 [NCBI] 7.85634e-06
IKBKE [NCBI] 7.84997e-06
TK2 [NCBI] 7.74223e-06
UCP3 [NCBI] 7.66642e-06
RPS6 [NCBI] 7.63528e-06
CAST [NCBI] 7.63528e-06
RING1 [NCBI] 7.63528e-06
ANKRD1 [NCBI] 7.53466e-06
LDB3 [NCBI] 7.53466e-06
CHUK [NCBI] 7.51288e-06
IKBKB [NCBI] 7.49296e-06
SPTLC1 [NCBI] 7.43967e-06
CNTF [NCBI] 7.43395e-06
CHRNA1 [NCBI] 7.26425e-06
CBLB [NCBI] 7.10527e-06
NEDD8 [NCBI] 7.10527e-06
MEF2C [NCBI] 7.10527e-06
CHD4 [NCBI] 7.10527e-06
COL6A1 [NCBI] 6.76289e-06
PMP22 [NCBI] 6.73047e-06
ACHE [NCBI] 6.71211e-06
PPIB [NCBI] 6.64322e-06
SPG7 [NCBI] 6.53147e-06
EMD [NCBI] 6.42665e-06
EIF2AK2 [NCBI] 6.42665e-06
CNBP [NCBI] 6.37659e-06
MYOT [NCBI] 6.32797e-06
CACNA1S [NCBI] 6.28072e-06
SLC6A6 [NCBI] 6.28072e-06
LAMC1 [NCBI] 6.23475e-06
ALS2 [NCBI] 6.23475e-06
ATL1 [NCBI] 6.19001e-06
GDAP1 [NCBI] 6.02206e-06
SCD [NCBI] 6.02206e-06
IL3 [NCBI] 5.94399e-06
EDNRA [NCBI] 5.90628e-06
AAAS [NCBI] 5.79798e-06
FKRP [NCBI] 5.60039e-06
PC [NCBI] 5.60039e-06
RAB7A [NCBI] 5.56961e-06
AKT1 [NCBI] 5.48697e-06
CAV3 [NCBI] 5.48056e-06
MYOG [NCBI] 5.23888e-06
LIF [NCBI] 5.23242e-06
FOXC2 [NCBI] 5.21407e-06
CRYAB [NCBI] 5.18964e-06
TSC1 [NCBI] 5.18964e-06
REN [NCBI] 5.14182e-06
RYR1 [NCBI] 5.028e-06
ID2 [NCBI] 4.96329e-06
GH1 [NCBI] 4.92152e-06
CXCL11 [NCBI] 4.92152e-06
AQP4 [NCBI] 4.62092e-06
AIRE [NCBI] 4.62092e-06
GHRH [NCBI] 4.57022e-06
MYH7 [NCBI] 4.36718e-06
AR [NCBI] 4.36178e-06
GFAP [NCBI] 4.35797e-06
EIF4EBP1 [NCBI] 4.22669e-06
ABCA4 [NCBI] 3.89931e-06
DIABLO [NCBI] 3.82439e-06
PLG [NCBI] 3.75287e-06
CXCL9 [NCBI] 3.68445e-06
IGF1R [NCBI] 3.65603e-06
STAT3 [NCBI] 3.43025e-06
EDN1 [NCBI] 3.42113e-06
SOCS3 [NCBI] 3.38129e-06
CXCL10 [NCBI] 3.38129e-06
AREG [NCBI] 3.35014e-06
DAG1 [NCBI] 3.09524e-06
SMAD3 [NCBI] 3.04399e-06
IGF2 [NCBI] 3.04399e-06
NOS3 [NCBI] 3.01931e-06
LMNA [NCBI] 3.01901e-06
MAP2K1 [NCBI] 2.82212e-06
HSPB1 [NCBI] 2.81132e-06
SLC2A4 [NCBI] 2.7125e-06
PGF [NCBI] 2.67283e-06
GDNF [NCBI] 2.639e-06
DMPK [NCBI] 2.62474e-06
TGFBR1 [NCBI] 2.4223e-06
GJB1 [NCBI] 2.33493e-06
PLN [NCBI] 2.23836e-06
MS [NCBI] 2.11799e-06
NGF [NCBI] 1.71191e-06
CHAT [NCBI] 1.64177e-06
IL10 [NCBI] 1.10543e-06
CCK [NCBI] 9.34065e-07
BDNF [NCBI] 8.08084e-07
CAT [NCBI] 8.04164e-07
BCL2L1 [NCBI] 7.97349e-07
NOS2 [NCBI] 4.99371e-07
VEGFA [NCBI] 1.40966e-07
TNF [NCBI] 1.47839e-08




OMIM


OMIM Link Information
gain
01
spinal muscular atrophy, childhood, proximal, autosomal dominant [NCBI] 0.00485882
amyotrophy, monomelic [NCBI] 0.00305207
CMT1B [NCBI] 0.00231568
hereditary motor and sensory neuropathy v [NCBI] 0.00172453
LGMD2L [NCBI] 0.00164535
wieacker syndrome [NCBI] 0.00134595
SMAX1 [NCBI] 0.00130412
WDM [NCBI] 0.00130245
spinal muscular atrophy, facioscapulohumeral type [NCBI] 0.00121108
charcot-marie-tooth disease, dominant intermediate a [NCBI] 0.00121108
MEAX [NCBI] 0.000991039
HMN7A [NCBI] 0.000991039
HMN1 [NCBI] 0.000991039
SCA18 [NCBI] 0.000821081
muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus [NCBI] 0.000821081
arthrogryposis-like disorder [NCBI] 0.000821081
neuropathy, congenital, with arthrogryposis multiplex [NCBI] 0.000821081
SMA1 [NCBI] 0.000692742
SMA3 [NCBI] 0.000633002
CMT2G [NCBI] 0.000603963
spinocerebellar ataxia with rigidity and peripheral neuropathy [NCBI] 0.000603963
pontocerebellar hypoplasia, type 1 [NCBI] 0.000603963
ketoaciduria with mental deficiency and other features [NCBI] 0.000603963
giant axonal neuropathy, autosomal dominant [NCBI] 0.000603963
neuropathy, hereditary motor and sensory, with deafness, mental retardation, and absent sensory large myelinated fibers [NCBI] 0.000522538
RA [NCBI] 0.00048186
CMTX1 [NCBI] 0.0004728
DSMA3 [NCBI] 0.000469955
MPD2 [NCBI] 0.000469955
bulbar palsy, progressive, with sensorineural deafness [NCBI] 0.000431071
scheuermann disease [NCBI] 0.000431071
SCA4 [NCBI] 0.000400255
lethal congenital contracture syndrome 1 [NCBI] 0.000400255
FBXO32 [NCBI] 0.000393674
spinal muscular atrophy, proximal, adult, autosomal dominant [NCBI] 0.000387398
SLE [NCBI] 0.000386126
inclusion body myositis [NCBI] 0.000374771
SPG5A [NCBI] 0.000334214
optic atrophy, hearing loss, and peripheral neuropathy, autosomal recessive [NCBI] 0.000292256
ossified ear cartilages with mental deficiency, muscle wasting, and bony changes [NCBI] 0.000292256
scapuloperoneal syndrome, neurogenic, kaeser type [NCBI] 0.00028096
MTM1 [NCBI] 0.000278031
AMCN [NCBI] 0.000265637
CTS1 [NCBI] 0.000228195
CMT1A [NCBI] 0.000199196
SPG17 [NCBI] 0.000188087
HMN5 [NCBI] 0.000174773
tibial muscular dystrophy, tardive [NCBI] 0.00016138
EDMD2 [NCBI] 0.000150958
HSAN1 [NCBI] 0.000148678
SMA2 [NCBI] 0.000142435
roussy-levy hereditary areflexic dystasia [NCBI] 0.000140333
charcot-marie-tooth disease and deafness [NCBI] 0.000133013
RNF28 [NCBI] 0.000130704
charcot-marie-tooth disease, dominant intermediate b [NCBI] 0.000127074
myopathy, centronuclear, autosomal dominant [NCBI] 0.000122075
pena-shokeir syndrome, type i [NCBI] 0.00011876
HMN2A [NCBI] 0.000113963
NEM3 [NCBI] 0.00011314
hypertrophic neuropathy of dejerine-sottas [NCBI] 0.000111126
SMA4 [NCBI] 0.000110574
SCAR1 [NCBI] 0.000110574
spinal muscular atrophy with mental retardation [NCBI] 9.73447e-05
spinal muscular atrophy, ryukyuan type [NCBI] 9.73447e-05
myoclonus, hereditary, with progressive distal muscular atrophy [NCBI] 9.73447e-05
neuropathy, hereditary sensorimotor, with upper motor neuron, visual pathway and autonomic disturbance [NCBI] 9.73447e-05
charcot-marie-tooth disease, guadalajara neuronal type [NCBI] 9.73447e-05
facial dysmorphism with multiple malformations [NCBI] 9.73447e-05
muscular atrophy, malignant neurogenic [NCBI] 9.73447e-05
spinal muscular atrophy with microcephaly and mental subnormality [NCBI] 9.73447e-05
tendons, extensor, of fingers, anomalous insertion of [NCBI] 9.73447e-05
XMPMA [NCBI] 9.73447e-05
nathalie syndrome [NCBI] 9.73447e-05
myopathy, granulovacuolar lobular, with electrical myotonia [NCBI] 9.73447e-05
neuropathy, painful [NCBI] 9.73447e-05
MPZ [NCBI] 9.47509e-05
IKBKB [NCBI] 9.42581e-05
AMPD1 [NCBI] 8.98292e-05
HNA [NCBI] 8.40432e-05
glycogen storage disease ii [NCBI] 8.14745e-05
FRAP1 [NCBI] 8.01013e-05
NFKB1 [NCBI] 7.54697e-05
BDB2 [NCBI] 7.4912e-05
spinal muscular atrophy, scapuloperoneal [NCBI] 7.4912e-05
DCTN2 [NCBI] 7.47769e-05
TGD [NCBI] 7.18027e-05
RSMD1 [NCBI] 7.18027e-05
keratoderma, palmoplantar, with nail dystrophy and hereditary motor-sensory neuropathy [NCBI] 6.64697e-05
SCA11 [NCBI] 6.64697e-05
TTR [NCBI] 6.52662e-05
SPG20 [NCBI] 6.10013e-05
CMTX5 [NCBI] 6.10013e-05
SCA13 [NCBI] 6.10013e-05
angiolipomatosis, familial [NCBI] 6.10013e-05
EDMD [NCBI] 5.93307e-05
HNPP [NCBI] 5.75966e-05
FCMD [NCBI] 5.6497e-05
FHL1 [NCBI] 5.58054e-05
PMPCB [NCBI] 5.58054e-05
ANKRD2 [NCBI] 5.58054e-05
muscle glycogenosis, x-linked [NCBI] 5.37212e-05
creatine phosphokinase, elevated serum [NCBI] 5.37212e-05
SPG20 [NCBI] 5.24329e-05
TNFSF12 [NCBI] 5.24329e-05
SCA5 [NCBI] 5.10467e-05
SPMM [NCBI] 5.10467e-05
ALS4 [NCBI] 5.10467e-05
RB1CC1 [NCBI] 4.99265e-05
IBM3 [NCBI] 4.87629e-05
mitochondrial myopathy [NCBI] 4.87629e-05
microcephaly with spastic quadriplegia [NCBI] 4.87629e-05
NFKBIA [NCBI] 4.79302e-05
BCL3 [NCBI] 4.79302e-05
SCA12 [NCBI] 4.67712e-05
PHKA1 [NCBI] 4.6271e-05
ALS1 [NCBI] 4.55242e-05
myopathy, myosin storage [NCBI] 4.50063e-05
minicore myopathy with external ophthalmoplegia [NCBI] 4.50063e-05
IGHMBP2 [NCBI] 4.36109e-05
SPTLC1 [NCBI] 4.36109e-05
CMT2A2 [NCBI] 4.34224e-05
SCA14 [NCBI] 4.34224e-05
PMP22 [NCBI] 4.27039e-05
SETX [NCBI] 4.25094e-05
PPID [NCBI] 4.25094e-05
DCTN1 [NCBI] 4.25094e-05
RPS6 [NCBI] 4.25094e-05
CMT4A [NCBI] 4.19866e-05
LGMD2I [NCBI] 4.06741e-05
CMT2A1 [NCBI] 4.06741e-05
SYNS1 [NCBI] 4.06741e-05
COL6A2 [NCBI] 4.06194e-05
ANKRD1 [NCBI] 4.06194e-05
NM [NCBI] 3.94659e-05
CHRNA1 [NCBI] 3.90354e-05
DSMA1 [NCBI] 3.83469e-05
PPARGC1A [NCBI] 3.833e-05
STAT3 [NCBI] 3.7419e-05
COFS1 [NCBI] 3.73054e-05
EA1 [NCBI] 3.73054e-05
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis [NCBI] 3.63315e-05
SOD1 [NCBI] 3.56485e-05
SCCMS [NCBI] 3.54173e-05
FMD [NCBI] 3.54173e-05
sacral defect with anterior meningocele [NCBI] 3.54173e-05
MSTN [NCBI] 3.49189e-05
VED [NCBI] 3.45562e-05
myotonia congenita, autosomal dominant [NCBI] 3.29717e-05
bethlem myopathy [NCBI] 3.29717e-05
SCA10 [NCBI] 3.29717e-05
ATXN8OS [NCBI] 3.27757e-05
CAV3 [NCBI] 3.16859e-05
SCD [NCBI] 3.16859e-05
IL3 [NCBI] 3.13484e-05
carnitine palmitoyltransferase ii deficiency, late-onset [NCBI] 3.08772e-05
AAA [NCBI] 3.08772e-05
REN [NCBI] 3.0707e-05
GAN1 [NCBI] 3.02415e-05
cutis laxa, x-linked [NCBI] 3.02415e-05
EA2 [NCBI] 3.02415e-05
refsum disease [NCBI] 3.02415e-05
AQP4 [NCBI] 3.01057e-05
CNTF [NCBI] 2.99144e-05
SLC18A3 [NCBI] 2.98186e-05
C3 [NCBI] 2.98186e-05
DES [NCBI] 2.95399e-05
myopathy, myofibrillar, desmin-related [NCBI] 2.90491e-05
ornithine aminotransferase deficiency [NCBI] 2.87494e-05
AD [NCBI] 2.87261e-05
RUNX1 [NCBI] 2.84999e-05
mitochondrial complex i deficiency [NCBI] 2.84886e-05
andersen cardiodysrhythmic periodic paralysis [NCBI] 2.79494e-05
FSHMD1A [NCBI] 2.745e-05
AR [NCBI] 2.66101e-05
PC [NCBI] 2.5741e-05
CDSP [NCBI] 2.55287e-05
glycogen storage disease v [NCBI] 2.46685e-05
LGMD2A [NCBI] 2.42581e-05
CHAC [NCBI] 2.42581e-05
MEB [NCBI] 2.38599e-05
RYR1 [NCBI] 2.36112e-05
SPG3A [NCBI] 2.30975e-05
COH1 [NCBI] 2.20306e-05
TSD [NCBI] 2.19624e-05
ACHE [NCBI] 2.08773e-05
SCA6 [NCBI] 2.07323e-05
DM2 [NCBI] 1.90046e-05
SCA7 [NCBI] 1.79742e-05
MB [NCBI] 1.77686e-05
RSTS [NCBI] 1.67994e-05
PDCD8 [NCBI] 1.62319e-05
PLG [NCBI] 1.61682e-05
ND [NCBI] 1.55301e-05
AMC [NCBI] 1.53317e-05
NPS [NCBI] 1.53317e-05
MJD [NCBI] 1.48431e-05
FOP [NCBI] 1.36903e-05
SCA2 [NCBI] 1.35224e-05
SCA1 [NCBI] 1.05191e-05
OPMD [NCBI] 7.11378e-06
DRPLA [NCBI] 5.65087e-06
GDNF [NCBI] 5.4983e-06
TNF [NCBI] 4.96679e-06
PPARA [NCBI] 4.94643e-06
BCNS [NCBI] 4.6284e-06
CHAT [NCBI] 4.117e-06
HD [NCBI] 3.88485e-06
CHS [NCBI] 3.2017e-06
GFAP [NCBI] 2.36723e-06
dystrophia myotonica 1 [NCBI] 2.02373e-06
NGFB [NCBI] 1.92071e-06
CCK [NCBI] 1.16151e-06
BDNF [NCBI] 9.77661e-07
TS [NCBI] 6.63225e-07
CRH [NCBI] 2.66428e-07
MG [NCBI] 5.68123e-08
VEGF [NCBI] 3.97927e-08




Database Center for Life Science